Results 201 to 210 of about 5,100,964 (347)

The neural crest‐associated gene ERRFI1 is involved in melanoma progression and resistance toward targeted therapy

Molecular Oncology, EarlyView.
ERRFI1, a neural crest (NC)‐associated gene, was upregulated in melanoma and negatively correlated with the expression of melanocytic differentiation markers and the susceptibility of melanoma cells toward BRAF inhibitors (BRAFi). Knocking down ERRFI1 significantly increased the sensitivity of melanoma cells to BRAFi.
Nina Wang, Qian Sun, Daniel Novak, Lei Zhu, Juliane Poelchen, Tamara Steinfass, Yiman Wang, Viktor Umansky, Jochen Utikal   +8 more
wiley   +1 more source

RETRACTION: A Survey and Proposed Framework on the Soft Biometrics Technique for Human Identification in Intelligent Video Surveillance System. [PDF]

Biomed Res Int
International BR.
europepmc   +1 more source

Interpretable Passive Multi-Modal Sensor Fusion for Human Identification and Activity Recognition. [PDF]

Sensors (Basel), 2022
Yuan L, Andrews J, Mu H, Vakil A, Ewing R, Blasch E, Li J.   +6 more
europepmc   +1 more source

Abstract 1199: Identification of candidate regulators of genomic instability in human lung adenocarcinoma through a new cross-speciesin silicoanalysis

, 2019
Chinthalapally V. Rao, Mudassir Farooqui, Yuting Zhang, Gaurav Kumar, Janani Panneerselvam, Nagendra Sastry Yarla, Adam S. Asch, Hiroshi Y. Yamada   +7 more
openalex   +1 more source

Identification of Small-Molecule Agonists of Human Relaxin Family Receptor 1 (RXFP1) by Using a Homogenous Cell-Based cAMP Assay [PDF]

, 2012
Catherine Z. Chen, Noel Southall, Jingbo Xiao, Juan Marugán, Marc Ferrer, Xin Hu, Raisa E. Jones, Shu Feng, Irina U. Agoulnik, Wei Zheng, Alexander I. Agoulnik   +10 more
openalex   +1 more source

Plasma extrachromosomal circular DNA as a biomarker in EGFR‐targeted therapy of non‐small cell lung cancer

Molecular Oncology, EarlyView.
Detection of extrachromosomal circular DNA (eccDNA) in plasma samples from EGFR‐mutated non‐small cell lung cancer patients. Plasma was collected before and during treatment with the EGFR‐tyrosine kinase inhibitor osimertinib. Plasma eccDNA was detected in all cancer samples, and the presence of the EGFR gene on eccDNA serves as a potential biomarker ...
Simone Stensgaard, Sarmad Mehmood, Eva Boysen Fynboe Ebert, Peter Meldgaard, Anindya Dutta, Boe S. Sorensen   +5 more
wiley   +1 more source

Identification and Characterisation of Novel Cone Photoreceptor-Enriched Factors Conserved in Zebrafish, Mouse and Human

, 2016
Andrew J. H. Smith, Conor Daly, Ross F. Collery, Vijender Chaitankar, Matthew Brooks, Tiziana Cogliati, Anand Swaroop, Breandán N. Kennedy   +7 more
openalex   +1 more source

Identification of an Extracellular Domain within the Human PiT2 Receptor That Is Required for Amphotropic Murine Leukemia Virus Binding [PDF]

, 2003
Steven A. Feldman, Karen B. Farrell, Ravi Murthy, Jill L. Russ, Maribeth V. Eiden   +4 more
openalex   +1 more source

Glycosylated LGALS3BP is highly secreted by bladder cancer cells and represents a novel urinary disease biomarker

Molecular Oncology, EarlyView.
Urinary LGALS3BP is elevated in bladder cancer patients compared to healthy controls as detected by the 1959 antibody–based ELISA. The antibody shows enhanced reactivity to the high‐mannose glycosylated variant secreted by cancer cells treated with kifunensine (KIF).
Asia Pece, Giulio Lovato, Ilaria Cela, Arianna Mercatelli, Benedetta Ferro, Jussi Nikkola, Sara Pagotto, Tommaso Grottola, Vincenzo De Laurenzi, Rossella Cicchetti, Antonio Marchetti, Luigi Schips, Rossano Lattanzio, Stefano Iacobelli, Emily Capone, Peter Black, Mads Daugaard, Michele Marchioni, Gianluca Sala   +18 more
wiley   +1 more source

Human identification through 3D images: 
a comparative method based on common dental morphological traits. [PDF]

J Forensic Odontostomatol
Silva AC, Teixeira A, Pinho T, Pérez-Mongiovi D.   +3 more
europepmc   +1 more source